DIFGEN PHARMS vs Medline Industries, LP: FDA Enforcement Comparison

Medline Industries, LP has been the subject of 341 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for DIFGEN PHARMS.

DIFGEN PHARMS: 0 warning letters, 0 recalls, 1 approval record, 0 Form 483s.

Medline Industries, LP: 0 warning letters, 341 recalls, 0 approval records, 0 Form 483s.

Side by side

DIFGEN PHARMS — Warning letters0

Medline Industries, LP — Warning letters0

DIFGEN PHARMS — Recalls0

Medline Industries, LP — Recalls341

DIFGEN PHARMS — Approval records1

Medline Industries, LP — Approval records0

DIFGEN PHARMS — Form 483s0

Medline Industries, LP — Form 483s0

Timeline

DIFGEN PHARMS

Most recent FDA action: September 15, 2026

Full history →

Medline Industries, LP

Most recent FDA action: September 9, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"DIFGEN PHARMS vs Medline Industries, LP: FDA Enforcement Comparison." Argus HQ, accessed September 23, 2026. https://argushq.ai/compare/difgen-pharms-vs-medline-industries-lp

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗